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Abstract: BACKGROUND Intracranial arteriovenous malformations (AVMs) are rare lesions that can
be congenital or acquired in early childhood, with fatal outcome in approximately 30% of cases. De novo
formation during adulthood without established predisposing vascular pathology or previous brain insult
is even less frequent. CASE DESCRIPTION We present a case of de novo brain AVM in an alcoholic
Child-B cirrhosis setting. Thirty previously reported cases presented de novo AVM in patients of all ages
that had another previous brain pathology or insult, such as AVM resection. Seventeen of those cases
occurred in adult patients, with only 2 showing no significant predisposing factor. The present patho-
physiological review covers and completes Mullan’s hemodynamic ”two-hit” model, associating probable
thrombotic predisposition to AVM with brain insult triggering a later stage based on angiogenic stimuli.
CONCLUSIONS This case report and literature review renews previously discussed hemodynamic theo-
ries and contributes to a fuller understanding of the pathogenesis and progression of AVM. We postulate
a causal link between hepatopathy and de novo AVM, which should be strengthened and interpreted
based on recent genetic data and future prospective studies.
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AVF- Arteriovenous fistula 
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du foie (cirrhose); angiogenèseAVM- Arteriovenous malformation 
Child - Child-Pugh classification scale (severity of liver cirrhosis) 
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CT- Computed tomography 
CVM- Cerebral venous malformation 
DSA- Digital Subtraction Angiography 
DVA- Developmental venous anomaly 
HHT- Hereditary hemorrhagic telangiectasia 
HPS- Hepato-pulmonary syndrome 
IL-6 - interleukin-6 
MMP-3 and MMP-9- matrix metalloproteinases 3 and 9 
MRI- Magnetic resonance imaging 
PAVF- Pulmonary arteriovenous fistula 
NO- Nitric oxide 
TGF- Transforming growth factor 
TNF- α - Tumor necrosis factor- α 
VEGF- Vascular endothelial growth factor 
HIGHLIGHTSIntracranial arteriovenous malformation can also appear during late adulthood 
 Hepatopathy is linked with de novo AVM formation 
 AVM formation implicates both venous congestion/thrombosis and arterial phase-related 
changes  
ABSTRACT 
Background: Intracranial arteriovenous malformations (AVMs) are rare lesions that can be congenital 
or acquired in early childhood, with fatal outcome in approximately 30% of cases. De novo formation 
during adulthood without established predisposing vascular pathology or previous brain insult is even 
less frequent. 
KEYWORDS 
Spontaneous appearance; de novo; arteriovenous malformation (AVM); chronic liver disease 
(cirrhosis); angiogenesis 
Case Description: We present a case of de novo brain AVM in an alcoholic Child-B cirrhosis setting. 
Thirty previously reported cases presented de novo AVM in patients of all ages that had another 
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previous brain pathology or insult, such as AVM resection. Seventeen of those cases occurred in adult 
patients, with only 2 showing no significant predisposing factor. The present pathophysiological 
review covers and completes Mullan’s hemodynamic “two-hit” model, associating probable 
thrombotic predisposition to AVM with brain insult triggering a later stage based on angiogenic 
stimuli. 
Conclusions: This case report and literature review renews previously discussed hemodynamic 
theories and contributes to a fuller understanding of the pathogenesis and progression of AVM. We 
postulate a causal link between hepatopathy and de novo AVM, which should be strengthened and 
interpreted based on recent genetic data and future prospective studies. 
Contexte: Les malformations artérioveineuses intracrâniennes (MAV) sont des lésions rares pouvant 
être congénitales ou acquises dans la petite enfance, avec une issue potentiellement fatale chez environ 
30% des patients. La formation de novo à l'âge adulte sans qu'une pathologie vasculaire prédisposante 
n’ai été décrite est encore moins fréquente. 
Description du cas: Nous présentons le cas d'une MAV intracrânienne nouvellement formée dans un 
contexte de cirrhose alcoolique CHILD B. Trente cas précédemment rapportés ont montré la présence 
de MAV de novo chez des patients de tout âge présentant une autre pathologie vasculaire, telle que la 
résection préalable de MAV. Dix-sept de ces cas sont survenus chez des patients adultes, dont deux 
seulement sans aucun facteur prédisposant significatif. Dans notre revue physiopathologique, nous 
retrouvons et complétons le modèle hémodynamique en deux phases de Mullan, combinant une 
prédisposition thrombotique probable au développement de la MAVavec un dommage cérébral qui 
déclenche un stade ultérieur basé sur des stimuli angiogéniques. 
Conclusions: Cette description de cas et revue de la littérature renouvellent des théories 
hémodynamiques déjà discutées et contribuent à une meilleure compréhension intégrée de la 
pathogenèse et de l'évolution des MAV. Nous postulons un lien de causalité entre l'hépatopathie et la 
MAV de novo qui devrait être renforcé et interprété à la lumière des données génétiques récentes et de 
futures études prospectives. 
INTRODUCTION 
Intracranial arteriovenous malformation (AVM) is rare (incidence, 0.02-0.05%)1-3 and presents 
an annual hemorrhage rate of 2-4%1-3 with fatal outcome in approximately 30% of cases-3. This risk of 
bleeding depends on factors such as size, vessel morphology, intranidal aneurysm, etc. 1-2,4. 
The currently known pathophysiological concept describes AVM as either congenital or 
acquired in early childhood, developing gradually with time. Nevertheless, the fundamentals of AVM 
biology is still the subject of discussion and investigation3. 
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De novo formation during adulthood is rare but reported in several predisposing contexts and 
concomitant pathologies: radiotherapy, ischemia, moya-moya disease, venous sinus thrombosis, stem 
cell implantation, telangiectasia, traumatic brain injury, inflammatory/demyelinating conditions, sickle 
cell disease, seizure or resection of another similar lesion3,5. Only two cases have been described in 
adults where AVM developed without such vascular insults to the brain tissue5. 
We report here the case of de novo intracranial AVM in adulthood in a patient suffering from 
severe liver cirrhosis and with exclusion criteria for liver transplant, focusing the discussion on the 
possible angiogenesis and pathophysiologic mechanisms connecting the two diseases. 
CASE REPORT 
A 57-year-old female patient presented at the emergency department complaining of acute gait 
imbalance and left hemiparesis together with new dysarthria. The patient was known for chronic 
alcoholism with subsequent Child-B cirrhosis, complicated by hepato-pulmonary syndrome (HPS) and 
portal hypertension with gastropathy. A right-sided pre-central developmental venous anomaly (DVA 
without cavernoma) had also been incidentally diagnosed 2 years following head-trauma secondary to 
acute alcohol poisoning (Figure 1). At this point, despite T1-weighted gadolinium-enhanced 1mm 
MRI, no nidus, arterial feeder or edema was identified. 
Neurological examination confirmed a left-sided proportional hemiparesis with a pyramidal 
syndrome and slowed speech. 
New CT-angiography followed by MRI showed the previously diagnosed DVA, larger and 
completely changed, with an arteriovenous shunt and subsequent venous insufficiency and congestion 
resulting in surrounding vasogenic pre-central parenchymal edema. Cerebral digital subtraction 
angiography (DSA) confirmed this newly formed arteriovenous shunt between the DVA (draining in 
the superior sagittal sinus via the Trolard vein) and a peripheral cortical branch of the right anterior 
cerebral artery and also a distal branch of the external carotid artery (intra-osseous shunt), the whole 
meeting the diagnostic criteria of Spetzler-Martin grade 2 AVM6 (Figures 2 and 3). 
Taking into account the poor general condition of the patient, the eloquent AVM location and 
the overall prognosis, radiotherapy was discussed. Unfortunately the patient died 2 weeks later due to 
severe decompensated hepato-renal and hepato-pulmonary syndromes and rapidly progressive 
encephalopathy. 
DISCUSSION 
This is a rare case of de novo AVM in an adult aged over 35 years without history of 
hereditary hemorrhagic telangiectasia (HHT), moya-moya disease, intracranial aneurysm, 
arteriovenous fistula or venous sinus thrombosis, stem cell implantation, brain tumor resection and 
radiation, ischemic or hemorrhagic stroke, severe brain trauma, inflammatory state or any other 
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hereditary or acquired brain condition. Although there are an increasing number of case reports of de 
novo AVM, only 65,7-10 of the 36 reported cases5,7-31 occurred in adult patients without confirmed 
predisposing or concomitant pathology or brain insult. Four of these 6 cases occurred in a setting of 
chronic seizures7-10, 1 after a transient ischemic attack5 and 1 in a context of hepatopathy similar to the 
present case5. 
In 21 cases2,12,14-17,19,20,22-24,28-31, reported de novo AVM was reported in patients that had 
another vascular pathology, such as prior resection of an AVM in a different brain location during 
childhood, previous hemorrhagic stroke or intracranial aneurysm. The majority of the cases (n=19) 
were pediatric 11,15-26,31 and only 9 involved young adult patients (<35 years old)2,5,7,9,10,13,14,27,29. 
In vitro experimentation to evaluate AVM pathogenesis is limited in humans for clear ethical 
reasons. This gave rise to several theories based on scattered data from different fields, such as 
molecular biology and genetics, radiology, clinical reports and basic science1,3,5. Converging evidence 
suggests that AVM develops during the first trimester as, after this time, the adult forms of arterial and 
venous anatomy are complete and the number of pial-dural connections decreases. According to 
Mullan et al., after this initial shunt phase in the first trimester, the process of enlargement (to a point 
where the AVM becomes radiologically and/or clinically manifest) continues later in in-utero 
development or even after birth. It is followed by thrombosis within or loss of the developing cortical 
venous drainage in a particular location of the brain, diverting venous blood into deeper veins merging 
into a ‘venous star’ within the developing white matter. This venous star drains into a neighboring 
venous channel that may have superficial or deep venous drainage. Later on, this venous cluster 
fistulates and thus the region recruits arterial feeders. This theory was illustrated by 4 cases of mixed 
cerebral venous malformation (CVM) with AVM characteristics, described as ‘transition lesions’ 
demonstrating the progression from one to the other and suggesting that AVM is a fistulized CVM and 
that both relate to a failure in the development of the cortical venous mantle32. This process was 
theoretically claimed to be the main mechanism accounting for the association between DVA and 
cavernoma. In the present case, it can also be postulated that some preexisting form of small 
cavernoma or AVM unseen on imaging may have led to an early shunt-phenomenon with disruption 
of the normal endothelial spaces. 
The final step needed to complete this process is seen in brain AVM arising several years after 
an initial insult (thrombogenic, inflammatory, mechanical, ischemic/hypoxic or hormonal) in most 
patients. This suggests that these insults act as the “second-hit” to the existing acquired or genetic 
venous variant,19,33 leading to the pro-angiogenic state necessary for the arterial phase of AVM 
formation. Applying these ideas to the present case, the trigger may have been the hepatopathy. As 
peripheral systemic AVMs constitute a feature of advanced chronic liver disease, intracranial AVMs 
may also share a common etiology and mechanisms. These may involve excessive synthesis of nitric 
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oxide synthase, tumor necrosis factor-α (TNF- α), transforming growth factor (TGF) and vascular 
endothelial growth factor  (VEGF), matrix metalloproteinases (MMP-3 and MMP-9), interleukin-6 
(IL-6) or deficient estrogen hepatic metabolism, all of which are important in the inflammatory 
cascade and potent angiogenesis/fibrogenesis promotors, abundantly produced in AVM vessels, as 
revealed by immunohistochemistry3. A reported case of spontaneous resolution of AVM after liver 
transplantation favors this hypothesis34: after improvement of liver function resulting from the 
transplant, the AVM disappeared spontaneously together with the trigger factors. It should also be 
borne in mind that venous stenosis, occlusion, agenesis or thrombosis during embryologic 
development (as described by Mullan’s hemodynamic theory) 32 or chronic venous hypertension 
(hepatopathy) during childhood and adulthood can result in tissue hypoxia and hence contribute to 
angiogenesis. 
Lastly, our review showed that, 4 of the other 5 cases of de novo cerebral AVM without 
previous predisposing factors initially presented with seizures and 1 after TIA5,7-10, both of which are 
known to cause hypoxic-ischemic brain damage. This may lead to abundant production of the above-
mentioned potent angiogenic factors, such as VEGF and hypoxia-inducible growth factor 1 alpha 
(HIF-1α), in ischemic brain regions. Also significant overexpression of VEGF receptors and 
angioprotein receptors compared with controls was reported in patients with brain AVM3. 
Lasjaunias35 questioned the congenital theory of brain AVM, suggesting that it forms 
postnatally during childhood while the vascular tree is undergoing remodeling in response to changing 
local metabolic demands. AVM thus results from an aberration in the cycle of proliferation and 
apoptosis during this process. 
Looking at our case from a critical perspective, another interesting aspect was that prior DSA 
to formally rule out preexisting AVM and better characterize the initial DVA would have been ideal. 
Several reports confirmed the sensitivity of MRI in detecting intracranial AVM36. Being non-invasive 
and affording enhanced sensitivity, MRI is now considered the screening tool of choice for AVM, 
whereas DSA remains the gold standard in the work-up. MRI demonstrated sensitivity in detecting 
unruptured AVMs comparable to that of as CTA (97% vs 96%)37. 
Even so, the causal relationship discussed here has not yet been validated in vitro. With only a 
single case report it is not possible to conclude, or to recommend any change in follow-up protocol for 
this specific group of patients. Our understanding of the genetics, pathogenesis and progression of 
AVMs is in its infancy. 
CONCLUSION 
This was a rare case of spontaneous de novo brain AVM formation in an adult patient with 
liver cirrhosis. Together with previous reports and molecular and genetics studies, it highlights the 
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need to explore new paradigms in brain AVM pathogenesis while renewing the hemodynamic theories 
already postulated in the past. 
 The pathophysiology of cerebral AVM remains incompletely elucidated, but the theory of 
systematically congenital formation being challenged as de novo AVMs are increasingly being 
reported. 
We postulate a causal link between hepatopathy and de novo AVM, based firstly on venous 
hypertension/thrombosis-related changes plus a hepatic “second hit” that contributes to the pro-
angiogenic state resulting in the final AVM. This two-hit model combines a probable genetic 
predisposition to AVM development to subsequent insult to the brain, causing ischemia, inflammation, 
vascular proliferation, abnormal shunting, higher flow, increased shear stress and continued 
angiogenic stimulation. 
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LEGENDS 
Figure 1: T1-weighted MRI after gadolinium injection showing the presence of a 
developmental venous anomaly two years earlier without arteriovenous malformation (white arrows).  
Figure 2: CT-angiography and T1-weighted MRI with contrast showing the presence of a pre-
central arteriovenous malformation with an arteriovenous shunt and subsequent venous insufficiency 
and congestion resulting in peripheral vasogenic pre-central parenchymal edema.  
Figure 3: Cerebral digital subtraction angiography (DSA) confirmed this newly formed 
arteriovenous shunt between the developmental venous anomaly (draining in the superior sagittal sinus 
via a cortical vein) and a peripheral cortical branch of the right anterior cerebral artery and also a distal 
branch of the external carotid artery (intra-osseous shunt), the whole meeting the diagnostic criteria of 
Spetzler-Martin grade 2 arteriovenous malformation. 
